1966
DOI: 10.1007/bf00536225
|View full text |Cite
|
Sign up to set email alerts
|

Zur Differenzierung der Wirkung verschiedener Veratrum-Alkaloide auf die Lungendehnungsreceptoren und auf die Atemt�tigkeit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

1973
1973
1998
1998

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…These investigations were complemented by recordings of the activity of single fibres from pulmonary stretch receptors, which showed after veratridine injection an increased frequency in the inspiratory volleys, and tonic, frequency modulated activity, coupled with slowing of breathing. This has been confirmed for rabbits [Meier, Bein and Helmich, 1949], cats [Paintal, 1953] and guinea pigs [Zipf and Marquardt, 1966]. Thus the vagal pathway for the inhibitory effects of veratrum alkaloids on breathing is well established [see also Herzog, 1958; Hapke, 1963a and b].…”
mentioning
confidence: 56%
“…These investigations were complemented by recordings of the activity of single fibres from pulmonary stretch receptors, which showed after veratridine injection an increased frequency in the inspiratory volleys, and tonic, frequency modulated activity, coupled with slowing of breathing. This has been confirmed for rabbits [Meier, Bein and Helmich, 1949], cats [Paintal, 1953] and guinea pigs [Zipf and Marquardt, 1966]. Thus the vagal pathway for the inhibitory effects of veratrum alkaloids on breathing is well established [see also Herzog, 1958; Hapke, 1963a and b].…”
mentioning
confidence: 56%
“…With doses of the Veratrum ester alkaloids of the order required for hypotensive therapeutic action, respiratory effects usually are inconspicuous, except for a tachypnea with inspiratory emphasis which has been observed under experimental conditions (MOE et aI., 1944;ZIPF and MARQUARDT, 1966). Higher doses cause respiratory depression and apnea; e.g., in the guinea pig, doses of 1 to 15 [log/kg protoveratrine A led to tachypnea while apnea occurred at the dosage level of 20 [log/kg or above (ZIPF and MARQUARDT, 1966).…”
Section: B Respirationmentioning
confidence: 95%
“…Higher doses cause respiratory depression and apnea; e.g., in the guinea pig, doses of 1 to 15 [log/kg protoveratrine A led to tachypnea while apnea occurred at the dosage level of 20 [log/kg or above (ZIPF and MARQUARDT, 1966).…”
Section: B Respirationmentioning
confidence: 98%